BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 32374852)

  • 21. Utility of molecular markers in predicting local control specific to lung cancer spine metastases treated with stereotactic body radiotherapy.
    Shor D; Louie AV; Zeng KL; Menjak IB; Atenafu EG; Chia-Lin Tseng ; Detsky J; Larouche J; Zhang B; Soliman H; Myrehaug S; Maralani P; Hwang DM; Sahgal A; Chen H
    J Neurooncol; 2024 Apr; 167(2):275-283. PubMed ID: 38526757
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Normal tissue complication probability of vertebral compression fracture after stereotactic body radiotherapy for de novo spine metastasis.
    Chen X; Gui C; Grimm J; Huang E; Kleinberg L; Lo L; Sciubba D; Khan M; Redmond KJ
    Radiother Oncol; 2020 Sep; 150():142-149. PubMed ID: 32540335
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dose-Escalated 2-Fraction Spine Stereotactic Body Radiation Therapy: 28 Gy Versus 24 Gy in 2 Daily Fractions.
    Zeng KL; Abugarib A; Soliman H; Myrehaug S; Husain ZA; Detsky J; Ruschin M; Karotki A; Atenafu EG; Larouche J; Campbell M; Maralani P; Sahgal A; Tseng CL
    Int J Radiat Oncol Biol Phys; 2023 Mar; 115(3):686-695. PubMed ID: 36309076
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vertebral compression fracture (VCF) after spine stereotactic body radiation therapy (SBRT): analysis of predictive factors.
    Cunha MV; Al-Omair A; Atenafu EG; Masucci GL; Letourneau D; Korol R; Yu E; Howard P; Lochray F; da Costa LB; Fehlings MG; Sahgal A
    Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):e343-9. PubMed ID: 22658511
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vertebral compression fracture risk after stereotactic body radiotherapy for spinal metastases.
    Boehling NS; Grosshans DR; Allen PK; McAleer MF; Burton AW; Azeem S; Rhines LD; Chang EL
    J Neurosurg Spine; 2012 Apr; 16(4):379-86. PubMed ID: 22225488
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of stereotactic body radiotherapy and stereotactic radiosurgery in the re-irradiation of metastatic spinal tumors.
    Jain AK; Yamada YJ
    Expert Rev Anticancer Ther; 2014 Oct; 14(10):1141-52. PubMed ID: 25066490
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Salvage prostate re-irradiation using high-dose-rate brachytherapy or focal stereotactic body radiotherapy for local recurrence after definitive radiation therapy.
    Mbeutcha A; Chauveinc L; Bondiau PY; Chand ME; Durand M; Chevallier D; Amiel J; Kee DL; Hannoun-Lévi JM
    Radiat Oncol; 2017 Mar; 12(1):49. PubMed ID: 28274241
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Outcomes after reirradiation of spinal metastasis with stereotactic body radiation therapy (SBRT): a retrospective single institutional study.
    Sasamura K; Suzuki R; Kozuka T; Yoshimura R; Yoshioka Y; Oguchi M
    J Radiat Res; 2020 Nov; 61(6):929-934. PubMed ID: 32766715
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk factors for vertebral compression fracture after spine stereotactic body radiation therapy: Long-term results of a prospective phase 2 study.
    Mantel F; Sweeney RA; Klement RJ; Hawkins MA; Belderbos J; Ahmed M; Toussaint A; Polat B; Flentje M; Guckenberger M
    Radiother Oncol; 2019 Dec; 141():62-66. PubMed ID: 31526672
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stereotactic Body Radiotherapy for Spinal Metastases: Clinical Experience in 134 Cases From a Single Japanese Institution.
    Ito K; Ogawa H; Shimizuguchi T; Nihei K; Furuya T; Tanaka H; Karasawa K
    Technol Cancer Res Treat; 2018 Jan; 17():1533033818806472. PubMed ID: 30355246
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CT based quantitative measures of the stability of fractured metastatically involved vertebrae treated with spine stereotactic body radiotherapy.
    Hardisty M; Wright T; Campbell M; Burke M; Atenafu E; Cawricz M; Caldwell C; Yee A; Sahgal A; Whyne C
    Clin Exp Metastasis; 2020 Oct; 37(5):575-584. PubMed ID: 32643007
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stereotactic body radiotherapy for metastatic spinal sarcoma: a detailed patterns-of-failure study.
    Leeman JE; Bilsky M; Laufer I; Folkert MR; Taunk NK; Osborne JR; Arevalo-Perez J; Zatcky J; Alektiar KM; Yamada Y; Spratt DE
    J Neurosurg Spine; 2016 Jul; 25(1):52-8. PubMed ID: 26943256
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vertebral Fractures Following Stereotactic Body Radiotherapy for Spine Oligometastases: A Multi-institutional Analysis of Patient Outcomes.
    Abbouchie H; Chao M; Tacey M; Joon DL; Ho H; Guerrieri M; Ng M; Foroudi F
    Clin Oncol (R Coll Radiol); 2020 Jul; 32(7):433-441. PubMed ID: 32169302
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Feasibility of spine stereotactic body radiotherapy for patients with large tumors in multiple vertebrae undergoing re-irradiation: Dosimetric challenge using 3 different beam delivery techniques.
    Furuya T; Phua JH; Ito K; Karasawa K
    Med Dosim; 2019 Winter; 44(4):415-420. PubMed ID: 30929978
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reirradiation for isolated local recurrence of prostate cancer: Mono-institutional series of 64 patients treated with salvage stereotactic body radiotherapy (SBRT).
    Jereczek-Fossa BA; Rojas DP; Zerini D; Fodor C; Viola A; Fanetti G; Volpe S; Luraschi R; Bazani A; Rondi E; Cattani F; Vavassori A; Garibaldi C; Alessi S; Pricolo P; Petralia G; Cozzi G; De Cobelli O; Musi G; Orecchia R; Marvaso G; Ciardo D
    Br J Radiol; 2019 Feb; 92(1094):20180494. PubMed ID: 30379566
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of ambulatory patients with metastatic epidural spinal cord compression: a systematic review and meta-analysis.
    Van den Brande R; Thijs D; Bilsky M; Peeters M; Billiet C; Van de Kelft E
    J Neurosurg Spine; 2024 Feb; 40(2):175-184. PubMed ID: 37890190
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Spinal stereotactic body radiotherapy following intralesional curettage with separation surgery for initial or salvage chordoma treatment.
    Lockney DT; Shub T; Hopkins B; Lockney NA; Moussazadeh N; Lis E; Yamada Y; Schmitt AM; Higginson DS; Laufer I; Bilsky M
    Neurosurg Focus; 2017 Jan; 42(1):E4. PubMed ID: 28041314
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cumulative dose, toxicity, and outcomes of spinal metastases re-irradiation : Systematic review on behalf of the Re-Irradiation Working Group of the Italian Association of Radiotherapy and Clinical Oncology (AIRO).
    Pontoriero A; Lillo S; Caravatta L; Bellafiore F; Longo S; Lattanzi E; Parisi S; Fiorica F; Massaccesi M
    Strahlenther Onkol; 2021 May; 197(5):369-384. PubMed ID: 33635395
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk for surgical complications after previous stereotactic body radiotherapy of the spine.
    Roesch J; Cho JBC; Fahim DK; Gerszten PC; Flickinger JC; Grills IS; Jawad M; Kersh R; Letourneau D; Mantel F; Sahgal A; Shin JH; Winey B; Guckenberger M
    Radiat Oncol; 2017 Sep; 12(1):153. PubMed ID: 28893299
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy and safety of different fractions in stereotactic body radiotherapy for spinal metastases: A systematic review.
    Gong Y; Xu L; Zhuang H; Jiang L; Wei F; Liu Z; Li Y; Yu M; Ni K; Liu X
    Cancer Med; 2019 Oct; 8(14):6176-6184. PubMed ID: 31489788
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.